Search by Drug Name or NDC
NDC 00363-0421-68 Walgreens Effervescent Pain Relief 1000; 325; 1916 mg/1; mg/1; mg/1 Details
Walgreens Effervescent Pain Relief 1000; 325; 1916 mg/1; mg/1; mg/1
Walgreens Effervescent Pain Relief is a ORAL TABLET, EFFERVESCENT in the HUMAN OTC DRUG category. It is labeled and distributed by Walgreens. The primary component is ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE.
Product Information
| NDC | 00363-0421 |
|---|---|
| Product ID | 0363-0421_f0466c5c-f3f8-e95e-e053-2a95a90ace9d |
| Associated GPIs | 62100010002820 |
| GCN Sequence Number | 013486 |
| GCN Sequence Number Description | nicotine polacrilex GUM 4 MG BUCCAL |
| HIC3 | J3A |
| HIC3 Description | SMOKING DETERRENT AGENTS (GANGLIONIC STIM,OTHERS) |
| GCN | 03201 |
| HICL Sequence Number | 002049 |
| HICL Sequence Number Description | NICOTINE POLACRILEX |
| Brand/Generic | Generic |
| Proprietary Name | Walgreens Effervescent Pain Relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Aspirin, Citric Acid, Sodium Bicarbonate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, EFFERVESCENT |
| Route | ORAL |
| Active Ingredient Strength | 1000; 325; 1916 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE |
| Labeler Name | Walgreens |
| Pharmaceutical Class | Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Ac |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part343 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00363-0421-68 (00363042168)
| NDC Package Code | 0363-0421-68 |
|---|---|
| Billing NDC | 00363042168 |
| Package | 18 POUCH in 1 CARTON (0363-0421-68) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| Marketing Start Date | 2017-12-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |